Antioxidants and vitamins to reduce cardiovascular disease.

S. Devaraj, I. Jialal

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cardiovascular disease is the leading cause of morbidity and mortality in Western populations. Several lines of evidence support the role of oxidative stress in atherogenesis. Dietary micronutrients with antioxidant properties and vitamins have also been shown to have a benefit with regards to cardiovascular disease. The most persuasive evidence relates to alpha tocopherol and folate and vitamin B(12). Although the evidence is mounting for supplementation with alpha tocopherol and folate and B(12) for secondary prevention of cardiovascular disease, no clear consensus can be reached for primary prevention of cardiovascular disease. This will have to await results of ongoing clinical trials.

Original languageEnglish (US)
Pages (from-to)342-351
Number of pages10
JournalCurrent Atherosclerosis Reports
Volume2
Issue number4
StatePublished - Jul 2000
Externally publishedYes

Fingerprint

Vitamins
Cardiovascular Diseases
Antioxidants
alpha-Tocopherol
Folic Acid
Micronutrients
Primary Prevention
Vitamin B 12
Secondary Prevention
Atherosclerosis
Oxidative Stress
Clinical Trials
Morbidity
Mortality
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Antioxidants and vitamins to reduce cardiovascular disease. / Devaraj, S.; Jialal, I.

In: Current Atherosclerosis Reports, Vol. 2, No. 4, 07.2000, p. 342-351.

Research output: Contribution to journalArticle

Devaraj, S & Jialal, I 2000, 'Antioxidants and vitamins to reduce cardiovascular disease.', Current Atherosclerosis Reports, vol. 2, no. 4, pp. 342-351.
Devaraj, S. ; Jialal, I. / Antioxidants and vitamins to reduce cardiovascular disease. In: Current Atherosclerosis Reports. 2000 ; Vol. 2, No. 4. pp. 342-351.
@article{5afe801c689c4cf89455ec6333ce0867,
title = "Antioxidants and vitamins to reduce cardiovascular disease.",
abstract = "Cardiovascular disease is the leading cause of morbidity and mortality in Western populations. Several lines of evidence support the role of oxidative stress in atherogenesis. Dietary micronutrients with antioxidant properties and vitamins have also been shown to have a benefit with regards to cardiovascular disease. The most persuasive evidence relates to alpha tocopherol and folate and vitamin B(12). Although the evidence is mounting for supplementation with alpha tocopherol and folate and B(12) for secondary prevention of cardiovascular disease, no clear consensus can be reached for primary prevention of cardiovascular disease. This will have to await results of ongoing clinical trials.",
author = "S. Devaraj and I. Jialal",
year = "2000",
month = "7",
language = "English (US)",
volume = "2",
pages = "342--351",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Antioxidants and vitamins to reduce cardiovascular disease.

AU - Devaraj, S.

AU - Jialal, I.

PY - 2000/7

Y1 - 2000/7

N2 - Cardiovascular disease is the leading cause of morbidity and mortality in Western populations. Several lines of evidence support the role of oxidative stress in atherogenesis. Dietary micronutrients with antioxidant properties and vitamins have also been shown to have a benefit with regards to cardiovascular disease. The most persuasive evidence relates to alpha tocopherol and folate and vitamin B(12). Although the evidence is mounting for supplementation with alpha tocopherol and folate and B(12) for secondary prevention of cardiovascular disease, no clear consensus can be reached for primary prevention of cardiovascular disease. This will have to await results of ongoing clinical trials.

AB - Cardiovascular disease is the leading cause of morbidity and mortality in Western populations. Several lines of evidence support the role of oxidative stress in atherogenesis. Dietary micronutrients with antioxidant properties and vitamins have also been shown to have a benefit with regards to cardiovascular disease. The most persuasive evidence relates to alpha tocopherol and folate and vitamin B(12). Although the evidence is mounting for supplementation with alpha tocopherol and folate and B(12) for secondary prevention of cardiovascular disease, no clear consensus can be reached for primary prevention of cardiovascular disease. This will have to await results of ongoing clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0034230589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034230589&partnerID=8YFLogxK

M3 - Article

C2 - 11122764

AN - SCOPUS:0034230589

VL - 2

SP - 342

EP - 351

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 4

ER -